We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Brands / QUALIGEN

IS A TOP-SELLING SPANISH
PHARMACEUTICAL COMPANY

specialised in CNS therapeutic area
BRANDQUALIGEN_METAS_COMPANY_ALT

Qualigen

It is our mission to innovate and investigate pharmaceutical products, improving pharmaceutical form and finding better solutions adapted to patients' needs in the area of central nervous system disorders

Qualigen is specialised in commercialising branded and generic products with a strategic approach to central nervous system disorders.

The client focus is based on three fundamental pillars:

Salud (Health)
We contribute towards improving people's wellbeing by offering a portfolio of more than 120 products, including the main central nervous system reference drugs

Innovación (Innovation)
We are committed to domestic manufacturing and R&D that guarantees the highest quality. The investment goes beyond the patent: orodispersible and effervescent tablets, adapted doses, unique generics, etc

Calidad (Quality)
Our quality is based on the product, price and service, and is guaranteed by GMPs, ISO 9001:2000, ISO 14001, the FDA and external audits

Headquartered in Barcelona (Spain)
QUALIGEN IS THE SPANISH SUBSIDIARY
SPECIALISED IN COMMERCIALIZING DRUGS
with a strategic approach to products for CNS disorders

Focus

Pipeline with a strong focus on CNS pathologies
  • Schizophrenia
  • Bipolar disorder
  • Depression
  • Anxiety
  • Dementia
  • Parkinson's
  • Epilepsy
  • Neuropathic pain
  • Migraine

Portfolio

  • During our ten years of history we have launched more than 120 products, including the main central nervous system reference drugs. This means one new product each month

  • The current product portfolio includes more than 75 molecules in approximately 250 pharmaceutical forms, and we plan to introduce the same number of new launches in the coming years

  • Qualigen is the market leader for generic antipsychotics in Spain (IMS Dec. 2017) and holds a TOP3 position in Alzheimer's

  • During 2018, we are entering the pain area with 4 new products

clients

  • Patients 
    Our main focus is to find better solutions for CNS patients, making them the focal point of our product development and galenic research, and improving their quality of life

  • Professionals 
    We are committed to working together with CNS professionals (doctors, nurses, pharmacies, carers, etc…), investing in product research and development and offering services and support to improve patients's quality of life

  • Stakeholders

    Together, we seek to ensure the sustainability of the healthcare system, increasing the value of our products with new formulas that are better adapted to patients' needs

IN 2018, QUALIGEN CELEBRATES ITS 10th ANNIVERSARY

The company launched its first product in Spain in January 2008

Qualigen Is a top-selling spanish pharmaceutical company specialised in products for the CNS Therapeutic Area

Expertise in the central nervous system field allowing us to reach both retail pharmacists and medical specialists, mainly in the psychiatry, neurology and pain areas, in the domestic market in Spain with differentiated medicinal products